|Funding for:||UK Students, EU Students, International Students|
|Hours:||Full Time, Part Time|
|Placed On:||6th June 2019|
|Closes:||24th June 2019|
We are looking for exceptional students to apply for a funded PhD opportunity. This studentship is part of a work programme of the Economic Methods of Evaluation in Health and Social Care Interventions (EEPRU). This is a National Institute for Health Research-funded policy research programme undertaking work for the Department of Health and Social Care and arm’s-length bodies including NICE and NHS England. The studentship is in the following topic area:
Developing appropriate policy options to support commissioning and research investment decisions for antimicrobials under conditions of high uncertainty
Antimicrobial resistance is a major global health concern. Drug manufacturers are reluctant to develop new drugs, citing limited return on investment. In response to this, health care decision makers are recognising that payments from health care systems to drug manufacturers for antimicrobials need to reflect the value these treatments deliver to patients.
The UK Department of Health and Social Care is considering implementing an insurance-based delinked model for payment for antimicrobials. In order to set this payment at an appropriate level, an assessment of the value of the antimicrobial is required. Establishing the value of new antimicrobials is challenging as the use of antimicrobials will have impacts beyond the treated patient. Recent work has shown that, in principle, it is possible to quantify the benefits and costs of antimicrobials in terms of net health effects though this poses a number of modelling and evidential challenges. There are, therefore, likely to be high levels of uncertainty about the long-term benefits of new antimicrobials at launch. Given these uncertainties, it is important that funding decisions are flexible over time to accommodate the emergence of new research and surveillance data. The aim of this PhD is to further develop analytical methods for assessing alternative coverage with evidence development policies to reflect the specific features of antimicrobials.
The ideal candidate will have (or be about to complete) a Master’s degree in economics or a specialization within economics, with a substantial quantitative component. A good knowledge of decision analytic modelling and methods for economic evaluation are required.
Supervisory team: Beth Woods, Stephen Palmer
Full details on the topic area, eligibility criteria and application process are on the CHE website.
The successful candidate will be supervised in CHE and registered through the Department of Economics and Related Studies or the Department of Health Sciences. This is an opportunity to work in close contact with researchers in one of the most successful health economics research groups in the UK. CHE has a leading international reputation, and is one of the world’s largest health economics research centres.
CHE has an Athena SWAN Bronze award which recognises our commitment to good practice in recruiting, retaining and supporting the careers of women. We provide a supportive culture, family friendly work environment and support good work practices.
The award will cover academic fees at the UK/EU rate plus a maintenance stipend for 3 years (£15,009 in 2019/20). Non-EU/UK students will be expected to meet the cost of the difference between the UK/EU rate and the International (non-EU) rate.
Students are welcome to register full-time or part-time.
Applications should be received no later than Monday 24 June before 16.00h (UTC).
Shortlisted candidates will be interviewed. Interviews take place on Friday 19 July 2019.
Type / Role: